Joel D. Enas

555 total citations
25 papers, 468 citations indexed

About

Joel D. Enas is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Joel D. Enas has authored 25 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Organic Chemistry and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Joel D. Enas's work include Immunotherapy and Immune Responses (4 papers), Receptor Mechanisms and Signaling (4 papers) and Mitochondrial Function and Pathology (3 papers). Joel D. Enas is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Receptor Mechanisms and Signaling (4 papers) and Mitochondrial Function and Pathology (3 papers). Joel D. Enas collaborates with scholars based in United States, Canada and Finland. Joel D. Enas's co-authors include Chester A. Mathis, Scott Taylor, Anat Biegon, Stephen M. Hanrahan, Jukka Hartikka, Vesselina Bozoukova, William H. Okamura, Loretta Sukhu, Marilyn E. Ferrari and Marston Manthorpe and has published in prestigious journals such as Journal of the American Chemical Society, Brain Research and The Journal of Organic Chemistry.

In The Last Decade

Joel D. Enas

24 papers receiving 409 citations

Peers

Countries citing papers authored by Joel D. Enas

Since Specialization

Citations

This map shows the geographic impact of Joel D. Enas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel D. Enas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel D. Enas more than expected).

Fields of papers citing papers by Joel D. Enas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel D. Enas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel D. Enas. The network helps show where Joel D. Enas may publish in the future.

Co-authorship network of co-authors of Joel D. Enas

This figure shows the co-authorship network connecting the top 25 collaborators of Joel D. Enas. A scholar is included among the top collaborators of Joel D. Enas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel D. Enas. Joel D. Enas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Physical characterization and in vivo evaluation of poloxamer‐based DNA vaccine formulations 2008 ·The Journal of Gene Medicine ·Jukka Hartikka, Andrew J Geall, Vesselina Bozoukova, (unknown), Denis Rusalov, Joel D. Enas, Ji‐Hyun Yi, Antonio Nanci, Alain Rolland	32
2	Vaxfectin™-Formulated Influenza DNA Vaccines Encoding NP and M2 Viral Proteins Protect Mice against Lethal Viral Challenge 2007 ·Human Vaccines ·Gretchen S. Jimenez, (unknown), Qun Wei, Denis Rusalov, Andrew J. Geall, Joel D. Enas, Peggy Lalor, (unknown), (unknown), Catherine J. Luke, Alain Rolland, David C. Kaslow, Larry Smith	72
3	Mitochondrial Avid Radioprobes. Preparation and Evaluation of 7'(Z)-[125I]Iodorotenone and \n7'(Z)-[125I]Iodorotenol 2006 ·eScholarship (California Digital Library) ·Henry F. VanBrocklin, Stephen M. Hanrahan, Joel D. Enas, Nandanan Erathodiyil, James P. O’Neil	14
4	Mitochondrial avid radioprobes. Preparation and evaluation of 7′(Z)-[125I]iodorotenone and 7′(Z)-[125I]iodorotenol 2006 ·Nuclear Medicine and Biology ·Henry F. VanBrocklin, Stephen M. Hanrahan, Joel D. Enas, Nandanan Erathodiyil, James P. O’Neil	1
5	Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens 2001 ·Vaccine ·Jukka Hartikka, Vesselina Bozoukova, Marilyn E. Ferrari, Loretta Sukhu, Joel D. Enas, Michael Sawdey, Mary K. Wloch, (unknown), Jon Norman, Marston Manthorpe, Carl J. Wheeler	84
6	Vaxfectin enhances antigen specific antibody titers and maintains Th1 type immune responses to plasmid DNA immunization 2001 ·Vaccine ·(unknown), Jukka Hartikka, Vesselina Bozoukova, Loretta Sukhu, Walter K. Nishioka, Gita Singh, Marilyn E. Ferrari, Joel D. Enas, Carl J. Wheeler, Marston Manthorpe, (unknown)	47
7	Synthesis of [¹¹C]atipamezole, a potential PET ligand for the α₂‐adrenergic receptor in the brain 2001 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Dirk Roeda, (unknown), Yann Bramoullé, Joel D. Enas, (unknown), Frédéric Dollé, C. Crouzel	10
8	Synthesis of [F-18]fluoroatipamezole. Biodistribution in rats 1996 ·OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) ·Olof Solin, Joel D. Enas, Jörgen Bergman	4
9	Unexpected gem-Dimethyl-Carbonyl Rearrangement during Nitration of 6,6-Dimethyl-6,7,8,9-tetrahydro-5H- benzocyclohepten-5-one 1994 ·The Journal of Organic Chemistry ·(unknown), Joel D. Enas, Frank R. Fronczek, Henry F. VanBrocklin	5
10	2,2-Dimethyl-5-(dimethylamino)indan-1,3-dione 1994 ·Acta Crystallographica Section C Crystal Structure Communications ·(unknown), Joel D. Enas, Frank R. Fronczek	2
11	Indan-2,2-dicarboxylic acid, C11H10O4 1994 ·Acta Crystallographica Section C Crystal Structure Communications ·(unknown), Joel D. Enas, Frank R. Fronczek	0
12	Synthesis of ¹²³I‐and labelled 5‐iodo‐6‐nitroquipazine 1994 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Chester A. Mathis, Joel D. Enas, Stephen M. Hanrahan, Eyup Akgün	16
13	In vivo imaging of the 5-hydroxytryptamine reuptake site in primate brain using single photon emission computed tomography and [123I]5-iodo-6-nitroquipazine 1993 ·European Journal of Pharmacology ·William J. Jagust, Jamie L. Eberling, Jeffrey A. Roberts, Kathleen Brennan, Stephen M. Hanrahan, Henry F. VanBrocklin, Joel D. Enas, Anat Biegon, Chester A. Mathis	31
14	[125I]5-iodo-6-nitroquipazine: a potent and selective ligand for the 5-hyfroxytryptamine uptake complex. I. In vitro studies 1993 ·Brain Research ·Chester A. Mathis, Scott Taylor, Anat Biegon, Joel D. Enas	39
15	Structure of 2-ethyl-2-nitroindan-1,3-dione 1993 ·Acta Crystallographica Section C Crystal Structure Communications ·(unknown), Joel D. Enas, (unknown), Frank R. Fronczek	1
16	Nucleophilic aromatic substitution reactions with the fluoride ion: formation of 5-fluoro-indanones and indandiones related to atipamezole 1993 ·Journal of Fluorine Chemistry ·Joel D. Enas, (unknown), Chester A. Mathis, John M. Gerdes	2
17	[125I]5-Iodo-6-nitro-2-piperazinylquinoline: a potent and selective ligand for the serotonin uptake complex 1992 ·European Journal of Pharmacology ·Chester A. Mathis, Anat Biegon, Scott Taylor, Joel D. Enas, Stephen M. Hanrahan	30
18	Binding Potency of Paroxetine Analogues for the 5-Hydroxytryptamine Uptake Complex 1992 ·Journal of Pharmacy and Pharmacology ·Chester A. Mathis, John M. Gerdes, Joel D. Enas, (unknown), Scott Taylor, Yi Zhang, Dennis J. McKenna, (unknown), Stephen J. Peroutka	19
19	ChemInform Abstract: Studies on Vitamin D (Calciferol) and Its Analogues. Part 37. A‐Homo‐ 11‐hydroxy‐3‐deoxyvitamin D: Ring Size and π‐Facial Selectivity Effects on the (1,7)‐Sigmatropic Hydrogen Shift of Previtamin D to Vitamin D. 1991 ·ChemInform ·Joel D. Enas, J. Antonio Palenzuela, W. H. OKAMURA	1
20	Studies on vitamin D (calciferol) and its analogs. 37. A-Homo-11-hydroxy-3-deoxy vitamin D: ring size and .pi.-facial selectivity effects on the [1,7]-sigmatropic hydrogen shift of previtamin D to vitamin D 1991 ·Journal of the American Chemical Society ·Joel D. Enas, J. Antonio Palenzuela, William H. Okamura	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact